Idiopathic Thrombocytopenic Purpura - 26 Studies Found
| Terminated |
: A Phase 3, Multicenter, Randomized, Double-blind, Active-controlled, Parallel-group Trial With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Oral E5501 Versus Eltrombopag, in Adults With Chronic Immune Thrombocytopenia (Idiopathic Thrombocytopenic Purpura) : Idiopathic Thrombocytopenic Purpura : 2011-09-13 :
|
| Completed |
: Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients : Idiopathic Thrombocytopenic Purpura (ITP) : 2009-03-10 : Drug: PG2 500mg/vial, iv infusion, 3 ~ 5 times/week, 2.5 ~ 3.5 hr/time |
| Recruiting |
: Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients : Chronic Idiopathic Thrombocytopenic Purpura : 2015-11-19 : Drug: Hetrombopag Olamine |
| Completed |
: Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients : Idiopathic Thrombocytopenic Purpura (ITP) : 2006-08-09 : Drug: IgNextGen 10% Ig NextGen 10% is a liquid formulation |
| Completed |
: Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag : Idiopathic Thrombocytopenic Purpura : 2009-04-27 :
|
| Completed |
: Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura :
|
| Completed |
: Evaluating the Safety and Efficacy of AMG531 in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura(ITP) : Idiopathic Thrombocytopenic Purpura : 2005-05-20 : Drug: AMG 531 |
| Completed |
: Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) :
|
| Completed |
: Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic Purpura : Autoimmune Thrombocytopenic Purpura : 2005-04-11 : Drug: Doxil |
| Completed |
: Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura :
|